• Mechanism Helps Explain Persistence of Hepatitis C Virus
    Researchers at the University of California, San Diego School of Medicine have identified a mechanism that explains why people with the hepatitis C virus get liver disease and why the virus is able to persist in the body for so long. The hard-to-kill pathogen, which infects ...More
    4 days ago Posted in News
  • Studies Help Clarify Optimal Use of Combination Therapy in Chronic Hepatitis B Patients
    Three new studies presented at the International Liver Congress 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues (NUCs) to achieve the best treatment outcomes in patients with chronic hepatitis B (CHB). "Together ...More
    5 days ago Posted in News
  • New Chinese Herbal Medicine Shows Significant Potential in Treating Hepatitis C
    Data from a late-breaking abstract presented at the International Liver Congress 2014 identifies a new compound, SBEL1, that has the ability to inhibit hepatitis C virus (HCV) activity in cells at several points in the virus' lifecycle. SBEL1 is a compound isolated from ...More
    5 days ago Posted in News
  • New Combination Drug Therapy Proves Effective in Hepatitis C Treatments
    Treatment options for the 170 million people worldwide with chronic hepatitis C virus (HCV) are evolving rapidly, although the available regimens often come with significant side effects. Two multi-center clinical trials led by Beth Israel Deaconess Medical Center show ...More
    5 days ago Posted in News
  • Hepatitis C Treatment Cures More Than 90 Percent of Patients with Cirrhosis
    Twelve weeks of an investigational oral therapy cured hepatitis C infection in more than 90 percent of patients with liver cirrhosis and was well tolerated by these patients, according to an international study that included researchers from UT Medicine San Antonio and the ...More
    5 days ago Posted in News
  • New Data Reveal Positive Outcomes for Hepatitis C Transplant Patients
    New research announced at the International Liver Congress 2014 today provides new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C (HCV). As part of a compassionate use program, 104 post-liver transplant ...More
    2 weeks ago Posted in News
  • Viral Hepatitis More Deadly Than HIV in Europe
    Mortality from viral hepatitis is significantly higher than from HIV/AIDS across European Union countries, according to results from the Global Burden of Disease Study 2010 (GBD 2010) which was announced for the first time today at the International Liver Congress 2014. GBD ...More
    2 weeks ago Posted in News
  • EASL Releases Recommendations on the Management of Hepatitis C
    The European Association for the Study of the Liver (EASL) will this week be announcing new recommendations on the management of hepatitis C (HCV) at the International Liver Congress (ILC). These EASL recommendations reflect the approval of three new direct-acting ...More
    2 weeks ago Posted in News
  • WHO Issues Its First Hepatitis C Treatment Guidelines
    The World Health Organization (WHO) has issued its first guidance for the treatment of hepatitis C, a chronic infection that affects an estimated 130 million to 150 million people and results in 350,000 to 500,000 deaths annually. The publication of the "WHO Guidelines for ...More
    2 weeks ago Posted in News
  • Scientists Search for a Cure for Hepatitis B
    Two grants from the National Institutes of Health will allow Saint Louis University researchers to build on breakthroughs in understanding the hepatitis B virus and begin the search for a drug to cure – not just halt – the illness. Last year, John Tavis, PhD, ...More
    4 weeks ago Posted in News
« Previous12345678910114950Next »